An accurate, rapid and simple detection method plays an important role to quickly identify large number of COVID-19 infected patients and asymptomatic carriers to prevent virus transmission and assure timely treatment of patients. Thanks to the advancement of the technologies, numerous detection assays based on the nucleic acids and human sera are available. Moreover, other clinical diagnostic tools such as Chest CT imaging can also be used to improve and allow for the confirmation of infection. On the other hand, scientists have been racing to develop the vaccines and antiviral drugs against the virus. In addition, numerous programs and fund have been rolled out to support the development.
Here, Dr. Edward will be presenting a review of the nucleic acid- and sera-based detection assays for COVID-19 and the current trend of vaccine and drug development. In addition, he will be presenting how GenScript have helped in accelerating the research and development.
In this webinar, you will learn:
- Brief introduction of COVID-19
- Review of the currently available detection methods for SARS-CoV-2
- Discussion of the current trend of vaccine and drug development
Detection method for COVID-19 and vaccine development progress
Dr. Edward Wong is a field application scientist in GenScript. He completed his PhD degree from University of Adelaide. He worked as a Post Doctoral fellow at National Cancer Centre Singapore for 3 years and he had successfully reported the predictive factors for genetic screening of BRCA1 and BRCA2. He also reported the importance of genetic testing for 25 breast cancer-predisposition genes using NGS technology. Both of his works were reported in PlosOne and npj Genomic Medicine.